| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/27/1992 | EP0486944A2 Method of inhibiting tumor growth using xanthocillin X dimethylether |
| 05/27/1992 | EP0486908A2 TNF-Muteins |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | EP0201601B1 Glass microspheres |
| 05/27/1992 | CN1061411A Quinazolines derivatives for enhancing antitumor |
| 05/27/1992 | CN1016783B Promoting agent of activity of some antitumor agent against various kinds of tumor cell |
| 05/26/1992 | US5116992 Antitumor |
| 05/26/1992 | US5116949 Benzoyl urea compound-albumin complex |
| 05/26/1992 | US5116614 Jomol derivatives as agents for the use in malignant tumors and lowered immune defenses |
| 05/26/1992 | CA1301770C Isothiuronium salts |
| 05/26/1992 | CA1301756C Anti-tumour agents |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/22/1992 | CA2055168A1 Tnf-muteins |
| 05/21/1992 | WO1992008729A1 Antisense nucleic acid derivative |
| 05/21/1992 | CA2096658A1 Anti-sense nucleic acid derivative |
| 05/21/1992 | CA2055844A1 Slow-releasing composition of platinum-containing anticancer agent |
| 05/20/1992 | EP0485894A1 Semi-synthetic diastereomerically pure N-glycidyl-anthracyclines, methods for their preparation, and their use as cytostatics |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485530A1 TGF-$g(b) PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
| 05/20/1992 | EP0437556A4 Substitution analogues of magainin peptides |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/20/1992 | CN1061225A Epiodophylltoxin glucoside 4'-phosphate |
| 05/19/1992 | US5114967 Antibiotic alisamycin and its use |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | CA1301156C 4(3h)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives |
| 05/19/1992 | CA1301155C Diastereoisomeric tetrahydropyrido (2,3,-d)pyrimidine derivatives |
| 05/19/1992 | CA1301066C Anti-tumour substance and process for producing the same |
| 05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
| 05/15/1992 | CA2055334A1 Semisynthetic diastereomerically pure n-glycidylanthracyclines, a process for the steroselective preparation thereof and the use thereof as cytostatics |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007577A1 Antitumoral composition based on polypeptides having human interleukin 2 activity |
| 05/14/1992 | WO1992007570A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2071973A1 Antitumoral composition based on polypeptides having human interleukin 2 activity |
| 05/13/1992 | EP0485232A1 Neovascularisation inhibitors |
| 05/13/1992 | EP0485172A2 Esters and amides of substituted indenyl acetic acids |
| 05/13/1992 | EP0485157A2 Esters and amides of substituted pyrrole acetic acids |
| 05/13/1992 | EP0484870A2 Prodrugs for beta-lactamase and uses thereof |
| 05/13/1992 | EP0484856A2 Dynemicin C antitumor antibiotic |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0214299B1 Preparation of 5-fluoro-2'-deoxyuridine esters for intraarterial administration |
| 05/13/1992 | EP0195015B1 Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 05/12/1992 | US5112954 Antibodies specific for cancer cells |
| 05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112858 Antitumor agent |
| 05/12/1992 | US5112844 Micelles |
| 05/12/1992 | US5112837 Inhibitors of thymidylate synthetase enzyme |
| 05/12/1992 | US5112598 Vitamin a aerosol-inhalate preparations |
| 05/12/1992 | CA1300807C Heterocyclic derivatives |
| 05/12/1992 | CA1300612C Immunotherapeutic treatment |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2054569A1 Process for preparing benzo¬c|phenanthridinium derivatives, and novel compounds prepared by said process |
| 05/07/1992 | WO1992007844A1 Quinazolines derivatives for enhancing antitumor activity |
| 05/07/1992 | WO1992007567A1 Imidazolidinone compounds |
| 05/07/1992 | CA2095429A1 Imidazolidinone compounds |
| 05/07/1992 | CA2095213A1 Quinazoline derivatives for enhancing antitumor activity |
| 05/07/1992 | CA2055062A1 Prodrugs for beta-lactamase and uses thereof |
| 05/06/1992 | WO1992007466A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 05/06/1992 | EP0484027A1 Polysubstituted phthalocyanines |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483765A2 Method for activating lymphocyte |
| 05/06/1992 | EP0483667A2 Cyclic imino derivatives, process for their preparation and drugs containing them |
| 05/06/1992 | EP0301006B1 Methylprednisolone/sodium carboxymethyl starch tablet composition |
| 05/06/1992 | EP0248062B1 Medicaments |
| 05/06/1992 | CN1060788A Synergism of tnf and il-4 |
| 05/06/1992 | CN1060785A Natural anti-cancer leukonuclein made from animal spleens |
| 05/06/1992 | CA2095141A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 05/06/1992 | CA2054659A1 Dynemicin c antitumour antibiotic |
| 05/05/1992 | US5110925 Cardiotonic agents |
| 05/05/1992 | US5110919 Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates |
| 05/03/1992 | WO1992007558A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/03/1992 | WO1992007557A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 05/03/1992 | CA2072889A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
| 05/03/1992 | CA2072884A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/02/1992 | WO1992007866A1 Anthracycline analogues bearing latent alkylating substituents |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006973A1 Indole derivatives |
| 04/30/1992 | WO1992006707A1 Methods and compositions for the treatment of cell proliferation disorders |
| 04/30/1992 | WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs |
| 04/29/1992 | EP0483077A2 A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas. |
| 04/29/1992 | EP0482993A1 N,O-Spirocyclic derivatives of cyclotriphosphazenes, their preparation and their therapeutical use |
| 04/29/1992 | EP0482213A1 Antineoplastic agent |
| 04/29/1992 | EP0482172A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |